We are live on ! Find out more
ANIK icon

Anika Therapeutics
ANIK

157 hedge funds and large institutions have $403M invested in Anika Therapeutics in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 75 increasing their positions, 34 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 34

3.92% more ownership

Funds ownership: 89.83% → 93.75% (+3.9%)

3% less funds holding

Funds holding: 162 → 157 (-5)

6% less capital invested

Capital invested by funds: $429M → $403M (-$25.6M)

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

43% less call options, than puts

Call options by funds: $6.65M | Put options by funds: $11.6M

Holders
157
Holders Change
-5
Holders Change %
-3.09%
% of All Funds
3.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
75
Reduced
34
Closed
22
Calls
$6.65M
Puts
$11.6M
Net Calls
-$4.99M
Net Calls Change
-$4.69M

Top Buyers

1
Ameriprise
Ameriprise
Minnesota
+$15M
2
State Street
State Street
Massachusetts
+$7.72M
3
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management
California
+$5.98M
4
Baird Financial Group
Baird Financial Group
Wisconsin
+$5.44M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$5.14M

Top Sellers

1
First Manhattan
First Manhattan
New York
-$13.8M
2
EC
Engaged Capital
California
-$12.6M
3
AAM
AMI Asset Management
California
-$10.8M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.5M
5
PCM
Portolan Capital Management
Massachusetts
-$3.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$64.3M +$448K +13,068 +0.6%
Kayne Anderson Rudnick Investment Management
2
Kayne Anderson Rudnick Investment Management
California
$48.2M +$5.98M +174,716 +12%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$31M +$916K +26,738 +3%
Vanguard Group
4
Vanguard Group
Pennsylvania
$27.6M +$1.14M +33,425 +4%
State Street
5
State Street
Massachusetts
$22.1M +$7.72M +225,518 +45%
Ameriprise
6
Ameriprise
Minnesota
$19.5M +$15M +438,849 +214%
Renaissance Technologies
7
Renaissance Technologies
New York
$11.1M +$3.5M +102,277 +39%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$9.42M +$5.14M +150,115 +93%
BTW
9
Boston Trust Walden
Massachusetts
$7.97M +$479K +13,978 +6%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$7.82M +$8.36K +244 +0.1%
Millennium Management
11
Millennium Management
New York
$6.85M +$1.23M +36,009 +19%
Wells Fargo
12
Wells Fargo
California
$6.59M +$873K +25,480 +13%
Two Sigma Advisers
13
Two Sigma Advisers
New York
$6.57M +$3.14M +91,700 +73%
TAM
14
THB Asset Management
Connecticut
$6.22M -$1.06M -31,003 -13%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$5.98M +$665K +19,420 +11%
Northern Trust
16
Northern Trust
Illinois
$5.84M -$10.5K -307 -0.2%
Two Sigma Investments
17
Two Sigma Investments
New York
$5.4M +$1.18M +34,577 +24%
Baird Financial Group
18
Baird Financial Group
Wisconsin
$5.11M +$5.44M +158,906 +1,581%
Citadel Advisors
19
Citadel Advisors
Florida
$4.85M +$2.36M +69,050 +76%
Morgan Stanley
20
Morgan Stanley
New York
$4.44M +$2.97M +86,804 +144%
Invesco
21
Invesco
Georgia
$4.2M -$623K -18,195 -12%
Hotchkis & Wiley Capital Management
22
Hotchkis & Wiley Capital Management
California
$3.52M +$1.78M +51,910 +80%
Deutsche Bank
23
Deutsche Bank
Germany
$3.49M +$463K +13,517 +13%
Principal Financial Group
24
Principal Financial Group
Iowa
$3.45M -$40.3K -1,178 -1%
CM
25
Capital Management
Virginia
$3.39M +$349K +10,177 +10%
1
2 3 4 5

ANIK Hedge Fund Activity: Q1 2019 in Review

157 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q1 2019, worth a combined $403M — down 6% from $429M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ANIK and 19 opened new positions — a net loss of 3 holders — while 34 trimmed existing stakes and 75 added.

The largest buyer was Ameriprise, adding an estimated $15M. The largest seller was First Manhattan, exiting entirely with an estimated $13.8M sold.

  • 157 institutional investors held Anika Therapeutics (ANIK) as of Q1 2019, down from 162 in Q4 2018.
  • Funds reported $403M of Anika Therapeutics stock for Q1 2019, down 6% quarter-over-quarter.
  • 19 funds opened new Anika Therapeutics positions in Q1 2019 and 22 closed out, a net change of -3 holders.
  • The largest Anika Therapeutics buyer in Q1 2019 was Ameriprise, an estimated $15M added.
  • The largest Anika Therapeutics seller in Q1 2019 was First Manhattan, an estimated $13.8M sold.

Based on aggregated 13F filings for Q1 2019.